Clinical Trial: Micro-ultrasound-Guided Focal Laser Ablation for Intermediate-Risk Prostate Cancer: Safety & Effectiveness

U.S., Jan. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07339943) titled 'Micro-ultrasound-Guided Focal Laser Ablation for Intermediate-Risk Prostate Cancer: Safety & Effectiveness' on Sept. 04, 2025.

Brief Summary: This clinical research study is intended to show that Micro-Ultrasound Guided Focal Laser Ablation (MicroUSgFLA) is a safe procedure that can significantly postpone or eliminate the need for patients with intermediate-Risk prostate cancer (PCa) to undergo a definitive treatment (i.e., Radical Prostatectomy or Radiation Therapy) for their disease.

Study Start Date: April 30, 2025

Study Type: INTERVENTIONAL

Condition: Prostate Cancer (Adenocarcinoma) Low and Intermediate Risk Prostate Cancer...